... And losartan was no better than placebo

被引:6
作者
Messerli, FH [1 ]
机构
[1] Alton Ochsner Med Fdn & Ochsner Clin, Hypertens Dis Sect, Dept Internal Med, New Orleans, LA 70121 USA
关键词
D O I
10.1038/sj.jhh.1000926
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:649 / 650
页数:2
相关论文
共 9 条
[1]  
Andersson Ove K., 1998, Blood Pressure, V7, P53
[2]  
Bunt T, 1999, AM J HYPERTENS, V12, P79
[3]  
*DIV CARD DRUG PRO, PROP GUID CLIN EV AN
[4]   A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL STUDY OF VARIOUS DOSES OF LOSARTAN POTASSIUM COMPARED WITH ENALAPRIL MALEATE IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
GRADMAN, AH ;
ARCURI, KE ;
GOLDBERG, AI ;
IKEDA, LS ;
NELSON, EB ;
SNAVELY, DB ;
SWEET, CS .
HYPERTENSION, 1995, 25 (06) :1345-1350
[5]   A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension [J].
Hedner, T ;
Oparil, S ;
Rasmussen, K ;
Rapelli, A ;
Gatlin, M ;
Kobi, P ;
Sullivan, J ;
Oddou-Stock, P .
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) :414-417
[6]   Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan, in mild-to-moderate hypertension [J].
Kassler-Taub, K ;
Littlejohn, T ;
Elliott, W ;
Ruddy, T ;
Adler, E .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (04) :445-453
[7]   ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension [J].
Maillon, JM ;
Siche, JP ;
Lacourcière, Y .
JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (10) :657-664
[8]  
MESSERLI FH, 1999, IN PRESS ABCS ANTIHY
[9]   An elective-titration study of the comparative effectiveness of two angiotensin II receptor blockers, irbesartan and losartan [J].
Oparil, S ;
Guthrie, R ;
Lewin, AJ ;
Marbury, T ;
Reilly, K ;
Triscari, J ;
Witcher, JA .
CLINICAL THERAPEUTICS, 1998, 20 (03) :398-409